Clinical Trial Update: Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD? [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigates whether early re-administration of aspirin and clopidogrel increases bleeding risk after endoscopic mucosal resection (EMR…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastric Dysplasia

Drugs mentioned

• Aspirin (Aspirin)
• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Asan Medical Center | Conditions: Early Gastric Cancer, Gastric Dysplasia | Phase 4 | Status: UNKNOWN